• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将颗粒形成与非天然α-糜蛋白酶原 A 聚集物的盐和 pH 依赖性相分离相关联。

Relating particle formation to salt- and pH-dependent phase separation of non-native aggregates of alpha-chymotrypsinogen A.

机构信息

Department of Chemical and Biomolecular Engineering, and Center for Molecular Thermodynamics, University of Delaware, Newark, Delaware 19716, USA.

出版信息

J Pharm Sci. 2012 Oct;101(10):3651-60. doi: 10.1002/jps.23264. Epub 2012 Jul 17.

DOI:10.1002/jps.23264
PMID:22806414
Abstract

Visible and subvisible particle formation during the storage of protein solutions is of increasing concern for pharmaceutical products. Previous work (Li Y, Ogunnaike BA, Roberts CJ. 2010. J Pharm Sci 99:645-662) showed that the model protein, alpha-chymotrypsinogen A (aCgn), forms non-native aggregates under accelerated (heated) conditions, but the size and morphology of the resulting aggregates depended sensitively on pH and NaCl. Here, it is shown that aggregates created as high-molecular-weight soluble aggregates undergo a pH- and salt-dependent reversible phase transition to a condensed or insoluble phase of suspended microparticles, whereas monomers remain completely soluble in the same regime. The location of the phase boundary is quantitatively consistent with the different regimes of kinetic behavior observed previously for aCgn. This suggests that the while kinetics is important for controlling the rates of monomer loss during non-native aggregation, it may be possible to tune solution thermodynamics and phase behavior to suppress otherwise soluble aggregates from propagating to form visible or large subvisible particles. Interestingly, the aggregate phase boundary is sensitive to the identity of salt anions in solution, highlighting the importance of electrostatics and preferential salt interactions in mediating aggregate condensation and particle formation.

摘要

在蛋白质溶液储存过程中可见和亚可见颗粒的形成引起了人们对药物产品越来越多的关注。先前的工作(Li Y, Ogunnaike BA, Roberts CJ. 2010. J Pharm Sci 99:645-662)表明,模型蛋白α-糜蛋白酶原 A(aCgn)在加速(加热)条件下形成非天然聚集物,但聚集物的大小和形态对 pH 和 NaCl 敏感依赖。在这里,研究表明形成的高分子量可溶性聚集物经历了一个 pH 和盐依赖性的可逆相转变,从可溶的凝聚或不溶的悬浮微粒子相转变,而单体在相同条件下仍完全可溶。相边界的位置与先前观察到的 aCgn 不同动力学行为的不同区域定量一致。这表明,虽然动力学对于控制非天然聚集过程中单体损失的速率很重要,但可能可以调节溶液热力学和相行为,以抑制原本可溶的聚集物进一步传播形成可见或较大的亚可见颗粒。有趣的是,聚集相边界对溶液中盐阴离子的特性敏感,突出了静电作用和优先盐相互作用在调节聚集物凝聚和颗粒形成中的重要性。

相似文献

1
Relating particle formation to salt- and pH-dependent phase separation of non-native aggregates of alpha-chymotrypsinogen A.将颗粒形成与非天然α-糜蛋白酶原 A 聚集物的盐和 pH 依赖性相分离相关联。
J Pharm Sci. 2012 Oct;101(10):3651-60. doi: 10.1002/jps.23264. Epub 2012 Jul 17.
2
Multi-variate approach to global protein aggregation behavior and kinetics: effects of pH, NaCl, and temperature for alpha-chymotrypsinogen A.多变量方法研究全局蛋白质聚集行为和动力学:α-糜蛋白酶原 A 的 pH、NaCl 和温度影响。
J Pharm Sci. 2010 Feb;99(2):645-62. doi: 10.1002/jps.21869.
3
Non-native aggregation of alpha-chymotrypsinogen occurs through nucleation and growth with competing nucleus sizes and negative activation energies.α-胰凝乳蛋白酶原的非天然聚集通过成核和生长过程发生,存在竞争的核尺寸和负活化能。
Biochemistry. 2007 Jun 26;46(25):7558-71. doi: 10.1021/bi700296f. Epub 2007 May 27.
4
Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.非天然聚集 IgG1 抗体在酸性条件下,第 2 部分:成核和生长动力学与竞争生长机制。
J Pharm Sci. 2011 Jun;100(6):2104-19. doi: 10.1002/jps.22447. Epub 2011 Jan 6.
5
Molecular level insights into thermally induced α-chymotrypsinogen A amyloid aggregation mechanism and semiflexible protofibril morphology.热诱导α-糜蛋白酶原 A 淀粉样纤维聚集机制和半刚性原纤维形态的分子水平研究
Biochemistry. 2010 Dec 14;49(49):10553-64. doi: 10.1021/bi1014216. Epub 2010 Nov 18.
6
Aggregate structure, morphology and the effect of aggregation mechanisms on viscosity at elevated protein concentrations.在蛋白质浓度升高时,聚集体结构、形态以及聚集机制对粘度的影响。
Biophys Chem. 2015 Dec;207:21-9. doi: 10.1016/j.bpc.2015.07.002. Epub 2015 Jul 17.
7
Reduction of the C191-C220 disulfide of α-chymotrypsinogen A reduces nucleation barriers for aggregation.α-糜蛋白酶原 A 的 C191-C220 二硫键的还原降低了聚集的成核势垒。
Biophys Chem. 2014 Jan;185:79-87. doi: 10.1016/j.bpc.2013.11.005. Epub 2013 Nov 28.
8
Thermodynamics of amyloid dissociation provide insights into aggregate stability regimes.淀粉样物解聚的热力学研究为聚集体稳定性的研究提供了新视角。
Biophys Chem. 2012 Jul;168-169:10-8. doi: 10.1016/j.bpc.2012.06.001. Epub 2012 Jun 7.
9
Protein adsorption, desorption, and aggregation mediated by solid-liquid interfaces.固液界面介导的蛋白质吸附、解吸和聚集
J Pharm Sci. 2015 Jun;104(6):1946-1959. doi: 10.1002/jps.24429. Epub 2015 Apr 2.
10
Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration.抗生物素蛋白免疫球蛋白 G1 的聚集涉及 Fab 展开和由 pH 值和盐浓度介导的竞争生长途径。
Biophys Chem. 2013 Feb;172:26-36. doi: 10.1016/j.bpc.2012.12.004. Epub 2012 Dec 26.

引用本文的文献

1
The Diagnosis and Management of Allergic Reactions Caused by Chinese Materia Medica.中药所致过敏反应的诊断与处理
Clin Rev Allergy Immunol. 2022 Feb;62(1):103-122. doi: 10.1007/s12016-020-08812-7. Epub 2021 Feb 19.
2
Ultra-rapid glutathionylation of chymotrypsinogen in its molten globule-like conformation: A comparison to archaeal proteins.糜蛋白酶原在无规卷曲状态下的超快速谷胱甘肽化:与古菌蛋白的比较。
Sci Rep. 2020 Jun 2;10(1):8943. doi: 10.1038/s41598-020-65696-5.
3
Hyperuricemia Predisposes to the Onset of Diabetes via Promoting Pancreatic β-Cell Death in Uricase-Deficient Male Mice.
尿酸酶缺乏型雄性小鼠中高尿酸血症通过促进胰岛β细胞死亡而导致糖尿病的发生。
Diabetes. 2020 Jun;69(6):1149-1163. doi: 10.2337/db19-0704. Epub 2020 Apr 20.
4
Modulating non-native aggregation and electrostatic protein-protein interactions with computationally designed single-point mutations.通过计算设计的单点突变调控非天然聚集和静电蛋白质-蛋白质相互作用。
Protein Eng Des Sel. 2016 Jun;29(6):231-243. doi: 10.1093/protein/gzw010. Epub 2016 May 9.
5
Combined dynamic light scattering and Raman spectroscopy approach for characterizing the aggregation of therapeutic proteins.结合动态光散射和拉曼光谱法表征治疗性蛋白质的聚集
Molecules. 2014 Dec 12;19(12):20888-905. doi: 10.3390/molecules191220888.
6
Protein aggregation and its impact on product quality.蛋白质聚集及其对产品质量的影响。
Curr Opin Biotechnol. 2014 Dec;30:211-7. doi: 10.1016/j.copbio.2014.08.001. Epub 2014 Aug 28.
7
Therapeutic protein aggregation: mechanisms, design, and control.治疗性蛋白质聚集:机制、设计与控制。
Trends Biotechnol. 2014 Jul;32(7):372-80. doi: 10.1016/j.tibtech.2014.05.005. Epub 2014 Jun 4.
8
High-throughput biophysical analysis of protein therapeutics to examine interrelationships between aggregate formation and conformational stability.蛋白质治疗药物的高通量生物物理分析,以研究聚集体形成与构象稳定性之间的相互关系。
AAPS J. 2014 Jan;16(1):48-64. doi: 10.1208/s12248-013-9539-6. Epub 2013 Oct 31.
9
Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques.雷达图阵列分析可视化制剂变量对多种分析技术测量的 IgG1 颗粒形成的影响。
J Pharm Sci. 2013 Dec;102(12):4256-67. doi: 10.1002/jps.23738. Epub 2013 Oct 9.